Hereditary Spastic Paraplegia Type 50: Clinical Trials

1 trial for Hereditary Spastic Paraplegia Type 50, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Hereditary Spastic Paraplegia Type 50: new trials by email Literature Review of Hereditary Spastic Paraplegia Type 50 trials Research Report on Hereditary Spastic Paraplegia Type 50

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls.
MELPIDA - Hereditary Spastic Paraplegia Type 50
Phase 3RecruitingElpida Therapeutics SPC242026-04-012026-04-20

Narrower conditions

Paraplegia (1)

Broader conditions

Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Paralysis (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Sponsors

Elpida Therapeutics SPC (1)

Countries

Spain (1)  ·  United States (1)

Results publications

PMID 41491634